Roche partners on epigenomic analysis; Microsoft strikes mHealth deal;

> Roche ($RHHBY) partnered with the Garvan Institute to develop targeted epigenomic analysis technologies. News

> Microsoft ($MSFT) struck a deal with TracFone to run a mHealth pilot project in diabetes patients. Item

> FDA officials discussed their stance on approval of NGS assays. Feature

> OmniComm Systems reported record contract growth in the first half of the year. Release

> Seven Bridges provided an update on its open-source, cloud-based workflow for cancer genomics. Article